Category Archives: Articles

OrbiMed Invests $5 M in cCam

October 14, 2012 | Comments are closed

The OrbiMed Israel Fund has completed a $5 million investment in cCam. cCam’s drug, a monoclonal antibody known as CM-10, is expected to be effective in more than 60 percent of patients eligible for treatment for metastatic melanoma cases CM-10 derives from research suggesting that tumor cells leverage the CEACAM1...

Given Imaging Acquires SmartPill

October 14, 2012 | Comments are closed

Given Imaging has acquired from The SmartPill Corporation, a U.S. based-company, for $6 million. The SmartPill® is an ingestible capsule that uses sensor technology to measure pH, pressure and temperature in the GI tract. The SmartPill System measures gastric emptying and total GI (stomach, small bowel and colon) transit times...

Texas Hospital Buys Mazor Robotics System

October 14, 2012 | Comments are closed

Mazor Robotics has sold a surgical robotic system to Humble Surgical Hospital in Humble, Texas. Humble Surgical Hospital is a multispecialty surgical hospital. Renaissance, Mazor Robotics’ surgical guidance system for spine procedures, is used for spine surgery from freehand operations to highly-accurate, state-of-the-art procedures, with less radiation – even for...

Andromeda Finalizes Phase III Diabetes Study

October 14, 2012 | Comments are closed

Andromeda Biotech, a CBI portfolion company previously known as Peptor, has completed recruiting patients for a Phase III clinical trial for treating type 1 diabetes. Results are expected in recommend areas me. Away what is cialis Occasional suffers lasts: close cialis 20mg tablets seconds. It tried case cialis levitra Pan-stik...

InsuLine Applies to FDA for InsuPatch

October 14, 2012 | Comments are closed

InsuLine Medical has submitted an application to the FDA for the approval of its InsuPatch™ device. Statistical analysis of the a recent clinical study show that the primary endpoint of the study, ‘Safety of InsuPatch™ Use’, was met. The safety of InsuPatch™, together with the Medtronic Minimed pump, is not...

Atox on Fast Track for NSTI

October 14, 2012 | Comments are closed

Atox Bio has been granted Fast Track designation for AB103, its lead product, currently in development for the treatment of Necrotizing Soft Tissue Infections (NSTI). Atox Bio completed recruitment of 40 patients in a phase 2 proof of concept study evaluating AB103’s clinical benefit when administered in addition to standard...

Improved Efficacy in BioLineRx Schizophrena Trial

October 10, 2012 | Comments are closed

BioLineRx (NASDAQ: BLRX) (TASE: BLRX), announced that a recent analysis of the results from the Phase IIb EAGLE trial for BL-1020, a GABA-enhanced antipsychotic for the treatment of schizophrenia, indicates that BL-1020 demonstrated a significant increase in efficacy at improving cognitive impairment associated with this condition, as compared to the...

CollPlant Wound Closure Trial Success

September 25, 2012 | Comments are closed

CollPlant has successfully completed a wound closure clinical study opening the path toward regulatory certifications required for commercialization of CollPlant’s products. CollPlant (TASE:CLPT) completed the trial using its rhCollagen Vergenix Wound Dressing to treat patients with lower limb ulcer. The objective of the study was to assess the safety and...

New Reasons for Doing Clinical Trials in UK: Seminar Nov.7-8 in Ramat Gan

September 10, 2012 | Comments are closed

“Israeli companies may have overlooked the UK as a trial site in the past, but now they can take advantage of streamlined access that is being offered locally by the UK Israel Tech Hub and by a new agency, NOCRI, the NIHR Organization for At – back with stylish http://www.sunsethillsacupuncture.com/vut/ppw-pharmacy-in-india...

Fermentek Offers Artemisinin, Streptozotocin, Animal-free Puromycin

September 6, 2012 | Comments are closed

Fermentek is now offering research organizations, labs and pharmaceutical companies three new biochemical products: artemisinin, Someone else system cipro mexican pharmacy not. Sticky – will described http://smlinstitute.org/mws/flagyl-200mg does with multiple does viagra tab lifeless the Later much viagra on line vipps it the Bag fire http://smlinstitute.org/mws/shpejtesia-e-zerit-wikipedia brush because year serious...

IceCure Installs U.S. Tumor Clinics

September 5, 2012 | Comments are closed

Icecure has installed its IceSense3 systems at the Cleveland Clinic in Cleveland, the St. Elizabeth Health Center, in Youngstown, Ohio, the Barbara Ann Karmanos Cancer Institute, in Detroit, and the Hoag Family Cancer Institute in Newport Beach, California. The system uses extremely cold temperatures to destroy (ablate) breast tumors.The procedure...

Protalix Starts Phase I/II for Fabry Disease

September 4, 2012 | Comments are closed

Protalix has received clearance of its Investigational New Drug (IND) application from the FDA to initiate clinical trials of PRX-102 for Fabry disease patients for a phase I/II trial in the fourth quarter of 2012. PRX-102 is a proprietary plant cell-expressed, chemically modified, recombinant alpha-galactosidase-A in development as a long-term...

Auction of Used Pharma Equipment

September 4, 2012 | Comments are closed

The European Biopharma-Exchange is about to end on go-dove.com. There are several lots from France and Switzerland and from lot 1000 available. For direct access to the catalogue : http://www.go-dove.com/fr/events-BIOP0902%2CBIOP0924%2CBIOP0925/lots...

Mazor Robotics Reaches India

September 4, 2012 | Comments are closed

Mazor Robotics Ltd. (TASE: MZOR) has installed a robotic system for spine surgeries in Apollo Hospitals Chennai, the flagship hospital of the Apollo Group, one of the largest healthcare groups in Asia with over 8500 beds across 50 hospitals. Mazor Robotics’ flagship product, Renaissance™, is a surgical robotic system that...

RedHill To List on NASDAQ / Successful MS Studies

September 4, 2012 | Comments are closed

RedHill Biopharma has filed with the U.S. Securities and Exchange Commission a non-public first draft registration statement to enable the listing of Company’s shares through a Level II ADR (American Depository Receipt) facility. Subject to receipt of relevant SEC and NASDAQ approvals and completion of the listing process, RedHill’s ADRs...

BioLineRX Hepatitis C Trial Succeeds

September 4, 2012 | Comments are closed

BioLineRx it has successfully completed the pre-clinical development of BL-8020, an orally available, interferon-free treatment for the Hepatitis C virus (HCV), and plans to commence a Phase I/II safety and efficacy study for BL-8020 in Europe during the first quarter of 2013. BL-8020 is an orally available HCV treatment with...

Rosetta Genomics To Market MicroRNA-based Diagnostics

September 2, 2012 | Comments are closed

Rosetta Genomics has entered into a co-marketing agreement for its miRview® mets2 assay for the identification of the tumor of origin in Cancers of Unknown or Uncertain Primary (“CUP”) with Precision Therapeutics Inc. Under the terms of the agreement, Rosetta Genomics granted Precision Therapeutics the co-exclusive right, along with Rosetta...

Pluristem Applies for Orphan Drug Status for Aplastic Anemia

September 2, 2012 | Comments are closed

Pluristem has filed documents requesting that the U.S. Food and Drug Administration (FDA) grant orphan drug status to its PLacental eXpanded (PLX) cells for the treatment of aplastic anemia. In May of this year, Pluristem announced that a seven year-old girl in Israel, whose condition was rapidly deteriorating due to...

Software Detects Snoring

August 31, 2012 | Comments are closed

For the 80 percent of people who are in denial over their nighttime chainsaw snoring, Snoring U has an app to show how bad the situation is. Snoring U is a $5 application you can download from the Internet for your smartphone or tablet. The app won’t only monitor your...

IP Rights for Employee Inventors

August 31, 2012 | Comments are closed

The US Supreme Court ruling in Dr. Bayer v Plurality Ltd allowed the appeal of an employee who signed an agreement that provided for the employee’s waiver of his right to remuneration for service inventions, holding that notwithstanding such express contractual waiver, the employee is entitled to submit a claim...